EDMONTON, ALBERTA--(MARKET WIRE)--Nov 14, 2007 -- Ceapro Inc. (CDNX:CZO.V - News) announced its proprietary diabetes test meal, CeaProve® will be distributed through an agreement with Gamma-Dynacare Medical Laboratories, one of the largest and most respected medical laboratories in Canada. CeaProve® is a new and very accessible screening device, complementary to existing tests for diabetes and pre-diabetes. It will be introduced as a pilot program in selected sites in Toronto and Montreal.
